US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving-Reference-Cited by-同舟云学术

US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving

Published:2024-03-01 Issue:3 Volume:81 Page:223
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Hoge Charles W.¹,Chard Kathleen M.²,Yehuda Rachel³

Affiliation:

1. Walter Reed Army Institute of Research, Silver Spring, Maryland

2. Cincinnati VA Medical Center, Cincinnati, Ohio

3. James J. Peters Veterans Affairs Medical Center, and Icahn School of Medicine at Mount Sinai, New York, New York

Abstract

This Viewpoint discusses the updated 2023 clinical practice guidelines issued by the US Department of Veterans Affairs and the US Department of Defense regarding treatment approaches for posttraumatic stress disorder.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2813978/jamapsychiatry_hoge_2024_vp_230041_1709150818.73791.pdf

Reference10 articles.

1. Trauma-focused psychotherapies for posttraumatic stress disorder: a systematic review and network meta-analysis.;Jericho;Acta Psychiatr Scand,2022

2. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial.;Sloan;JAMA Psychiatry,2018

3. Effect of written exposure therapy vs cognitive processing therapy on increasing treatment efficiency among military service members with posttraumatic stress disorder: a randomized noninferiority trial.;Sloan;JAMA Netw Open,2022

4. Nontrauma-focused meditation vs exposure therapy in veterans with posttraumatic stress disorder: a randomised controlled trial.;Nidich;Lancet Psychiatry,2018

5. Dialectical behavior therapy for posttraumatic stress disorder (DBT-PTSD) compared with cognitive processing therapy (CPT) in complex presentations of PTSD in women survivors or childhood abuse: a randomized clinical trial.;Bohus;JAMA Psychiatry,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel mechanisms of Anshen Dingzhi prescription against PTSD: Inhibiting DCC to modulate synaptic function and inflammatory responses;Journal of Ethnopharmacology;2024-10

2. Expanding Collaborative Moral Injury Research: Reflection on Moral, Contextual, Social, and Psychospiritual Models;Current Treatment Options in Psychiatry;2024-08-22

3. VA/Department of Defense Clinical Practice Guideline for PTSD and ASD;JAMA Psychiatry;2024-08-01